Jailani, Al-nadzfar .

HRN: 22-99-11  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2023
CEFUROXIME 1.5GM (VIAL)
04/30/2023
05/06/2023
IVTT
300mg
Q8
PCAP C
Waiting Final Action 
04/30/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
04/30/2023
05/04/2023
PO
2.5ml
OD
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: